Bispecific T-cell engagers (BiTEs) are artificial antibodies that produce an immune interaction through two specific domains directed to a T-cell and to a cancer cell, in the case of multiple myeloma the BiTEs are directed against BCMA and CD3 so far. The gene discussed is TNFRSF17; the disease is cancer.